Corvus Pharmaceuticals, Inc. ($CRVS)
Filing Information
| Accession Number | 0000947871-26-000079 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 30, 2026 |
| Document Date | Jan 28, 2026 |
| Document | View SEC Filing |
Transactions
26
Total Shares
420,000
Total Value
$1,119,373.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 30,000 | $15.00 | $450,000.00 | 30,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $9.70 | $145,500.00 | 45,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $12.50 | $187,500.00 | 60,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $3.61 | $54,150.00 | 75,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $2.00 | $30,000.00 | 90,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $3.27 | $49,050.00 | 105,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $2.74 | $41,100.00 | 120,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $2.60 | $39,000.00 | 135,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.99 | $14,848.50 | 150,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.96 | $14,475.00 | 165,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $2.49 | $37,350.00 | 180,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $1.64 | $24,600.00 | 195,000 | Direct | โ | View Details | |
Director | Common Stock | โ | Jan 28, 2026 | Exercise/Conversion | 15,000 | $2.12 | $31,800.00 | 210,000 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 30,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jan 28, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |